Tech Millionaire Bryan Johnson Quits Rapamycin: A Controversial Anti-Aging Endeavor
Bryan Johnson, the millionaire tech entrepreneur known for his hefty investments in anti-aging, has stopped using rapamycin after experiencing severe side effects. With the support of Perplexity AI CEO Aravind Srinivas, Johnson's decision has ignited debates on the risks and ethics of experimental longevity treatments.
Jan 17